Publications
Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick M, Vijan S: Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries. Annals of Internal Medicine 2005; 143:89-99.
Neumann PJ, Rosen A, Weinstein MC: Medicare and Cost-Effectiveness Analysis. The New England Journal of Medicine 2005; 353:1516-1522.
Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH: Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute versus blood pressure level. Circulation 2005; 112:3569-3576.
Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA: Should Resistance Testing be Performed in Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis. Clinical Infectious Diseases 2005; 41:1316-1323.
Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS 2005;19:1299-1308.
Neumann PJ, Rosen AB, Greenberg D, Olchanski NV, Pande R, Chapman RH, Stone PW, Ondategui-Parra S, Nadai J, Siegel JE, Weinstein MC. Can We Better Prioritize Resources for Cost-Utility Research? Medical Decision Making. 2005; 25:429-436.
Paltiel AD, Weinstein MC, Kimmel AD, Seage GR III, Losina E, Zhang H, Freedberg KA, Walensky RP: Expanded Screening for HIV in the United States – an Analysis of Cost-Effectiveness. The New England Journal of Medicine; 2005;352:586-595.
Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP: Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. Journal of Acquired Immune Deficiency Syndromes 2005; 39:69-77.
Rinfret S, Cohen DJ, Lamas GA, Fleischmann KE, Weinstein MC, Orav J, Schron E, Lee KL, Goldman L: Cost-effectiveness of dual-chamber pacing as compared with ventricular pacing for sinus-node dysfunction. Circulation 2005; 111: 165-72.
Aledort JE, Hook EW III, Weinstein MC, Goldie SJ: The cost-effectiveness of gonorrhea screening in urban emergency departments. Sexually Transmitted Diseases 2005; 32:425-436.
Elkin EB, Weinstein MC, Kuntz KM, Bunnell C, Weeks JC: Adjuvant ovarian suppression versus chemotherapy for premenopausal hormone-responsive breast cancer. Breast Cancer Research and Treatment 2005; 93:25-34.
Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA: Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. Antiviral Therapy 2005; 10:41-52.
Walensky RP, Weinstein MC, Kimmel AD, Seage GR III, Losina E, Sax PE, Zhang H, Smith HE, Freedberg KA, Paltiel AD: Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. American Journal of Medicine 2005; 118:292-300.
Teutsch SM, Berger ML, Weinstein MC: Comparative effectiveness: asking the right questions, choosing the right method. Health Affairs 2005; 24:128-132.
Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC: Cost-effectiveness of percutaneous radiofrequency ablation versus hepatic resection in patients with metastatic colorectal carcinoma. Radiology 2004; 233:729-739.
Salomon JA, Weinstein MC, Goldie SJ: Taking account of future technology in cost effectiveness analysis. British Medical Journal 2004; 329:733-736.
Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC: Cost-effectiveness of interferon beta-1a, interferon beta -1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis. Value in Health 2004;7:554-568.
Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR III, Smith HE, Zhang H, Freedberg KA: A therapeutic HIV vaccine: how good is good enough? Vaccine 2004; 22:4044-4053.
McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ: Cost-effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical patients. American Journal of Managed Care 2004;10:632-642.
Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ.: When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Economics 2004;13:429-36.
Goldie SJ, Kohli M Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E: Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Journal of the National Cancer Institute 2004; 96:604-615.
Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC: HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. Journal of Clinical Oncology 2004; 22:854-863.
Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ: Cost analysis of “bridging therapy” with low-molecular weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. American Journal of Cardiology 2004; 93:509-511.
Neumann PJ, Weinstein MC. Rational rationing: There is a way to get the most health care bang for the buck. Commonwealth 2004;9(3):9-10.
Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR: Principles of good research practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices – Modeling Studies. Value in Health 2003; 6:9-17.
Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ: Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA 2003; 290:228-237.
Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, Walensky RP, Sax PE, Freedberg KA: Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. American Journal of Medicine 2003;115:632-641.
Zupancic JAF, Richardson DK, O’Brien BJ, Schmidt B, Weinstein MC: Daily cost prediction model in neonatal intensive care. International Journal of Technology Assessment in Health Care 2003;19:330-338.
Zupancic JAF, Richardson DK, O’Brien BJ, Eichenwald EC, Weinstein MC: Cost-effectiveness analysis of pre-discharge monitoring for apnea of prematurity. Pediatrics 2003;111:146-152.
Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein MC, Franco E: A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV 16/18 vaccine. International Journal of Cancer 2003; 106:896-904.
Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ: Empirically calibrated model of hepatitis C virus infection in the United States. American Journal of Epidemiology 2002; 156:761-773.
Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS: Health economic evaluations: the special case of end-stage renal disease treatment. Medical Decision Making 2002; 22:417-430.
Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR III, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA: Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia. Archives of Internal Medicine 2002; 162:921-928.
Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ: Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Archives of Internal Medicine 2002; 162:2478-2486.
Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J, Weinstein MC: Comparison of health state utilities using community and patient preference weights derived from a survey patients with HIV/AIDS. Medical Decision Making 2002; 22:27-38.
Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC: Impact of referral patterns on the use of chemotherapy for lung cancer. Journal of Clinical Oncology 2002; 20:1786-1792.
Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK: Modeling for health care and other policy decisions: uses, roles, and validity. Value in Health 2001; 4:348-361.
Weinstein MC: Should physicians be gatekeepers of medical resources? Journal of Medical Ethics 2001; 27:268-274.
Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H, Kimmel AD, Freedberg KA: Genotypic resistance testing to guide the choice of therapy in HIV: clinical impact and cost-effectiveness. Annals of Internal Medicine 2001; 134:440-450.
Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ: The cost-effectiveness of combination antiretroviral therapy in HIV. The New England Journal of Medicine 2001; 344:824-831.
Tsevat J, Kuntz KM, Orav EJ, Weinstein MC, Sacks FM, Goldman L: Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. American Heart Journal 2001; 141:727-734.
Claxton K, Neumann PJ, Araki SS, Weinstein MC: Bayesian value of information analysis: an application to Alzheimer’s disease. International Journal of Technology Assessment in Health Care 2001; 1:38-55.
Halpern EF, Weinstein MC, Hunink MGM, Gazelle GS: Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making 2000; 20:314-322.
Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MGM, Goldman L, and Weinstein MC. Cost-effectiveness of cholesterol-lowering therapies according to individual patient characteristics. Annals of Internal Medicine. 2000 132:769-779.
Prosser LA, Koplan JP, Neumann PJ, and Weinstein MC. Barriers to Using Cost-Effectiveness Analysis in Managed Care Decision Making. American Journal of Managed Care 2000;6(2):173-187.
Kuntz KM, Tsevat J, Weinstein MC, and Goldman L. Expert panel vs. decision-analysis recommendations for postdischarge coronary angiography after myocardial infarction. JAMA 1999;282(23):2246-2251.
Wright JC and Weinstein MC. Gains in Life Expectancy from Medical Interventions Standardizing Data on Outcomes. The New England Journal of Medicine 1998;339:380-386.
Hunink MGM, Goldman L, Tosteson ANA, Mittleman MA, Goldman PA, Williams LW, Tsevat J, and Weinstein MC. The Recent Decline in Mortality from Coronary Heart Disease, 1980-1990: The Effect of Secular Trends in Risk Factors and Treatment. JAMA 1997;277: 535-542.
Goldie SJ, Weinstein MC, Kuntz KM, and Freedberg KA. The Costs, Clinical and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women. Annals of Internal Medicine 1999;130:97-107.
Weinstein MC and Manning WG, Jr. Theoretical Issues in Cost-Effectiveness Analysis. Journal of Health Economics 1997;121: 28.
Kuntz KM, Tsevat J, Goldman L, and Weinstein MC. Cost-Effectiveness of Routine Coronary Angiography after Acute Myocardial Infarction. Circulation 1996;94: 957-965.
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, and Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276: 1253-1258.
Gold ML, Siegel JE, Russell LB, and Weinstein MC. Cost-Effectiveness in Health and Medicine: The Report of the Panel on Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, Neutra RR, and McNeil BJ. Clinical Decision Analysis. Philadelphia: W. B. Saunders, 1980.